A retrospective study investigating efficacy of Ledipasvir/Sofosbuvir in hepatitis C genotype 1 and 4 patients for 8 or 12 weeks: a real world study
Latest Information Update: 13 May 2016
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
Most Recent Events
- 13 May 2016 New trial record
- 17 Apr 2016 Results presented at The International Liver Congress 2016